Hemarus

Hyderabad, India Founded: 2003 • Age: 23 yrs Acquired By Olam Agro
Specialty plasma derived biopharmaceuticals for bleeding disorders

About Hemarus

Hemarus is a Healthcare company based in Hyderabad (India) founded in 2003, and was acquired by Olam Agro in August 2011. Specialty plasma derived biopharmaceuticals for bleeding disorders. The company has 68 employees. The company was acqui-hired. Its focus areas include Life Sciences, Rare Diseases, Drugs and Hematology. Its legal entity in India is Hemarus Therapeutics Limited (U74220TG2003PLC041698).

Company details

Hemarus is an Indian Pharma manufacturer of plasma-derived biopharmaceuticals for bleeding disorders. Their products include human albumin, immunoglobulins, coagulation factor, fibrin sealant etc. Their plant has a capacity to process 130,000 litres of plasma annually.

  • Headquarters Hyderabad, India
  • Employees 68
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    •••• ••••
  • Website hemarus.co.in
  • Social LinkedIn
  • Acquired by Olam Agro (Aug 2011)
  • Legal Name Hemarus Therapeutics Limited
  • Date of Incorporation 16 Sep, 2003
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Key Metrics
  • Net Loss
    -₹3.1 Lakh

    FY 2025 · -34381% margin

  • EBITDA
    -₹3.1 Lakh

    FY 2025 · -34377% margin

  • Investors
  • Employee Count
    68
  • Acquired by
    Olam Agro

    (Aug 2011)

Investors in Hemarus

Hemarus has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Olam Agro.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Provider of farm gate sourcing-based processing and selling solutions for farmers
1989olamgroup.comSingapore, Singapore
Premium access

Investor details for Hemarus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Hemarus Therapeutics Limited (Hemarus)

Hemarus Therapeutics Limited is the primary company behind Hemarus. The board of Hemarus Therapeutics Limited currently have 3 directors; the longest-serving is Kavali Dharmendra, appointed in 2024. 17 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kavali Dharmendra
DIN 07984298
Director25 Oct 20242 yrsHemarus Therapeutics Limited
Balaraju Jittaboina
DIN 10818541
Director25 Oct 20242 yrsHemarus Therapeutics Limited
Santosh Kumar Surana
DIN 10818902
Director25 Oct 20242 yrsHemarus Therapeutics Limited

Financials of Hemarus

Figures of Hemarus Therapeutics Limited, the primary company behind Hemarus, for FY 2025. Net loss was -₹3.1 Lakh (-34381% margin). EBITDA was -₹3.1 Lakh (-34377% margin). Revenue has grown at a compounded annual rate of -98% over three years and -93% over five years.

  • -₹3.1 LakhNet loss · -34381% margin
  • -₹3.1 LakhEBITDA · -34377% margin
  • ₹10 LakhPaid-up capital
  • 68Employees (provident fund records)
  • -98%Revenue CAGR, 3 years
  • -93%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Hemarus Therapeutics Limited are on its company page.

Premium access

Detailed financial statements for Hemarus

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Hemarus

2 dated milestones of Hemarus across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Hemarus is founded.
  2. Exit Acquired by Olam Agro.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hemarus

Premium access

Complete news archive for Hemarus

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemarus

Hemarus was founded in 2003.

Hemarus is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Hemarus has 68 employees.

Annual revenue of Hemarus is $853.5K as on Mar 31, 2022.

Hemarus is an Indian Pharma manufacturer of plasma-derived biopharmaceuticals for bleeding disorders. Their products include human albumin, immunoglobulins, coagulation factor, fibrin sealant etc. Their plant has a capacity to process 130,000 litres of plasma annually.

Hemarus has 1 investor. Key investors include Olam Agro.

Hemarus operates through Hemarus Therapeutics Limited.

Yes. Hemarus was acquired by Olam Agro in August 2011.

The legal entities of Hemarus currently have 3 directors, including Kavali Dharmendra, Balaraju Jittaboina, Santosh Kumar Surana.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available